Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Otitis media (acute): antimicrobial prescribing

NICE guideline
Reference number: NG91
Published: 28 March 2018
Last updated: 11 March 2022

History

Guidance published

Equality impact assessment (PDF 188 KB)

Published:

11 March 2022
Consultation comments and responses (PDF 185 KB)

Published:

11 March 2022

Stakeholder list updated

Stakeholder list (PDF 49 KB)

Published:

11 March 2022

Declaration of interests

Register of interests (PDF 316 KB)

Published:

11 March 2022

Draft guidance consultation

Draft guidance consultation
Comments form (MSWord 67 KB)

Published:

29 November 2021
Draft guideline (PDF version) (PDF 379 KB)

Published:

29 November 2021
Evidence review (PDF 3.11 MB)

Published:

29 November 2021
Summary paper (PDF 192 KB)

Published:

29 November 2021
Equality impact assessment (PDF 202 KB)

Published:

30 November 2021

Committee list updated

Committee member list (PDF 158 KB)

Published:

29 November 2021

Stakeholder list updated

Stakeholder list (PDF 1.17 MB)

Published:

29 November 2021

Declaration of interests

Register of interests (PDF 321 KB)

Published:

30 November 2021

Committee meetings

Committee meeting: 6
Minutes (PDF 188 KB)

Published:

29 November 2021

Original development on 28 March 2018

Committee list updated
Committee member list (PDF 159 KB)

Published:

21 July 2021
Declaration of interests
Register of interests (PDF 491 KB)

Published:

28 March 2018
Equality and health inequalities assessment
Equality impact assessment (PDF 358 KB)

Published:

28 March 2018
Consultation comments published
Consultation comments and responses (PDF 506 KB)

Published:

28 March 2018
Scope published
Final scope (PDF 363 KB)

Published:

22 May 2018
Draft guidance consultation
Draft guidance consultation
Consultation document - visual summary (PDF 154 KB)

Published:

22 September 2017
Comments form (MSWord 64 KB)

Published:

22 September 2017
Draft guideline (PDF 558 KB)

Published:

22 September 2017
Equality impact assessment (PDF 346 KB)

Published:

22 September 2017
Evidence review (PDF 2.48 MB)

Published:

22 September 2017
Stakeholder list updated
Stakeholder list (PDF 44 KB)

Published:

02 October 2017
Committee meeting: 1 (Managing common infections meeting 1)
Minutes (PDF 250 KB)

Published:

21 March 2018
Committee meeting: 2 (Managing common infections meeting 4)
Minutes (PDF 227 KB)

Published:

21 March 2018
Committee meeting: 3 (Managing common infections meeting 5)
Minutes (PDF 224 KB)

Published:

21 March 2018
Committee meeting: 4 (Managing common infections meeting 6)
Minutes (PDF 224 KB)

Published:

21 March 2018
Committee meeting: 5 (Managing common infections meeting 12)
Minutes (PDF 249 KB)

Published:

21 March 2018